Celia Pamela Corona-Villalobos MD, Presenter: Nothing to Disclose

Linda Chi Hang Chu MD, Abstract Co-Author: Nothing to Disclose

Kristin Porter MD, PhD, Abstract Co-Author: Stockholder, Pfizer Inc

Yan Zhang MD, PhD, Abstract Co-Author: Nothing to Disclose

Neda Rastegar MD, Abstract Co-Author: Nothing to Disclose

Ihab R. Kamel MD, PhD, Abstract Co-Author: Nothing to Disclose

Stefan L. Zimmerman MD, Abstract Co-Author: Nothing to Disclose

The purpose of this exhibit is to describe, beyond volumes and function, emerging imaging techniques and their potential diagnostic and prognostic significance in non-ischemic cardiomyopathies by cardiac magnetic resonance (CMR) imaging.

1. Review the most common clinical presentation, and imaging findings in patients with non-ischemic cardiomyopathies including • Hypertrophic Cardiomyopathy (HCM) • Amyloidosis • Dilated cardiomyopathy • Arrhythmogenic right ventricular Cardiomyopathy (ARVD) • Myocarditis • Tako-tsubo Cardiomyopathy • Sarcoidosis • Iron overload Cardiomyopathy 2 Introduce novel MRI techniques for evaluation of non-ischemic cardiomyopathies including 4D flow phase contrast imaging, T1 mapping, T2 and T2* mapping and explain their potential significance in patient management. Outline Cardiac MR-imaging is commonly utilized in the diagnosis and prognosis of patients with non-ischemic cardiomyopathies. This exhibit provides a review of emerging imaging techniques and explains their potential utility in the clinical setting.

http://abstract.rsna.org/uploads/2014/14011229/14011229_t9yx.pdf

Corona-Villalobos, C, Chu, L, Porter, K, Zhang, Y, Rastegar, N, Kamel, I, Zimmerman, S, Beyond Volumes and Function: Tissue Characterization in Non-ischemic Cardiomyopathies by Cardiac Magnetic Resonance Imaging.  Radiological Society of North America 2014 Scientific Assembly and Annual Meeting, - ,Chicago IL. http://archive.rsna.org/2014/14011229.html